Efficacy and safety under field conditions of the new vaccine UBAC® against Streptococcus uberis intramammary infections in dairy cows

Home Knowledge Efficacy and safety under field conditions of the new vaccine UBAC® against Streptococcus uberis intramammary infections in dairy cows

Efficacy and safety under field conditions of the new vaccine UBAC® against Streptococcus uberis intramammary infections in dairy cows

To evaluate the ef­ficacy and safety under ­field conditions of the new vaccine UBAC® (HIPRA) through a multicenter, randomized, double blinded and placebo-controlled clinical trial.

About this article

Appeared in

National Mastitis Council, 2018

Date

Jun 11, 2018

Authors

Puig, A.; Perozo, E.; Roura, F.; Armengol, R.; Ponté, D.; Mallo, J.; Echevarria, J.M.; Arrieta, C.; Herrera, D.; Franquesa, O.; Urtado, L.; Calm, I.; Collado, R.; Prenafeta, T.; March, R.; Sabaté, D.

Summary

Incidence of animals with S. uberis CM was significantly lower in UBAC® group than in the Placebo group (Figure 2). Also, differences between groups in terms of incidence of animals with S. uberis ScM were not statistically significant.

Related products

Share this on

The contents of this page are country specific and aimed specifically at prescribing veterinarians.

This product is not available in {{ preferredCountry.title }}.

You will be redirected to our global site. Click on continue to visit our global site (available in English).

Confirm that you are a veterinary professional:

This product is not available in {{ countrySelect.title }}.

You will be redirected to our global site. Click on continue to visit our global site (available in English).

  • I am a veterinarian (otherwise please contact a veterinary professional)

Select your country:

Country {{countrySelect.title}}
  • Global (available in English)
  • {{country.title}}